GenoSan, Inc. is a laboratory benefit solutions and market access consulting company specializing in the genetic and diagnostic testing market. Specialty testing represents the fastest growing segment of healthcare and insurance reimbursement. There are currently tens of thousands of unique genetic tests on the market with several new tests per day being developed and marketed. Many are panel tests consisting of 20-50 or more genetic variants. This rapid expansion has created a complex and challenging coverage, coding, and reimbursement environment for both laboratories and insurance companies. GenoSan provides clarity to the chaotic landscape. We approach the market collaboratively by orchestrating workable solutions between payors, providers, and labs. Our experienced team coordinates access to innovative products while ensuring adherence to medical policy and appropriate billing practices. From responsible medical policy development to claims data analysis, GenoSan infuses an innovative methodology into this rapidly changing healthcare segment. We are comprised of an experienced team of fully accredited genetic counselors, clinical specialists, healthcare executives, Registered Medical Coders (RMC), Health Economic Outcomes Research (HEOR) professionals, Special Investigative Unit (SIU) authorities, and business analytic experts.